UMass Medical School’s research achievements in virology, immunology, host response, drug design and advanced therapeutics support an accelerated approach to crucial new research projects aimed at COVID-19 and the virus that causes it, SARS-CoV-2.
Investigators listed here are using expertise and insight developed while working on understanding and treating some of the world’s most challenging diseases. Successful research programs at UMass Medical School have developed vaccines or antiviral drugs for viruses such as HIV, Ebola, influenza and RSV; other UMMS labs are world leaders in the design and testing of new approaches to therapeutics, which they are now applying to SARS-CoV-2.
